Related Experiment Video

Updated: Aug 20, 2026

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
08:17

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

Internal and surface subpopulations of the major surface protease (MSP) of Leishmania chagasi

Chaoqun Yao1, Jiwen Luo, Christine Hsiao

  • 1VA Medical Center, University of Iowa, Iowa City, IA 52242, USA. chaoqun-yao@uiowa.edu

Molecular and Biochemical Parasitology
|January 25, 2005
PubMed

Insights

Major surface protease (MSP) abundance in Leishmania is regulated by its release from the cell surface. Internally located MSP remains stable, suggesting a key mechanism for controlling parasite evasion and macrophage interaction.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Cell Biology

Background:

  • Major surface protease (MSP) is crucial for Leishmania survival, aiding in evasion of host immune responses and enhancing macrophage phagocytosis.
  • Previous studies indicated a 14-fold increase in MSP protein during in vitro cultivation without a corresponding mRNA increase, suggesting post-transcriptional regulation.
  • Differential expression of MSP isoforms across parasite growth phases and effects of attenuation were previously observed.

Purpose of the Study:

  • To investigate the intracellular fate and stability of newly synthesized Major Surface Protease (MSP) in Leishmania promastigotes.
  • To determine the regulation of MSP abundance by analyzing its localization, stability, and release rates from the parasite surface.
  • To test the hypothesis that MSP loss from the surface is the primary regulator of its abundance.

Main Methods:

  • Metabolic labeling of Leishmania promastigotes to track newly synthesized MSP.
  • Differential fractionation to distinguish between surface-localized and internally retained MSP.
  • Pulse-chase experiments to assess the stability and turnover of both surface and internal MSP pools.
  • Quantification of MSP release rates from logarithmic and stationary phase promastigotes.

Main Results:

  • Approximately two-thirds of newly synthesized MSP is localized to the promastigote surface, while the remainder is retained intracellularly.
  • Intracellular MSP is highly stable, showing no significant degradation for up to 6 days post-synthesis.
  • Surface-localized MSP exhibits differential release rates depending on the promastigote growth phase (logarithmic vs. stationary).

Conclusions:

  • The stability of internally retained MSP and the regulated release of surface-bound MSP are key factors controlling the overall abundance of Major Surface Protease in Leishmania.
  • These findings support a model where the rate of MSP loss from the parasite surface is the principal mechanism governing its steady-state levels.
  • Understanding MSP regulation provides insights into Leishmania's host-pathogen interactions and immune evasion strategies.

More Related Videos

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites10:01

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...